MAPK1 and Alzheimer disease: Moreover, the expression level of SH-SY5Y cyclin D1 was also increased after treatment with Aβ1-42, suggesting that Aβ activation of the Ras-ERK signaling pathway may be one of the mechanisms by which Aβ induces cell cycle disorders and apoptosis, leading to neurodegeneration and neuronal loss in AD.